Home » Aeterna to Advance Cancer Trial After European Nod
Aeterna to Advance Cancer Trial After European Nod
Aeterna Zentaris said on Monday that it would complete a mid-stage European study for its AEZS-108 compound later this year after the ovarian cancer treatment received a key recommendation from European regulators.
guardian
guardian
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May